https://scholars.lib.ntu.edu.tw/handle/123456789/202022
標題: | Consensus Statement on Antimicrobial Therapy of Intra-Abdominal Infections in Asia | 作者: | Hsueh, Po-Ren Hawkey, Peter Michael |
關鍵字: | intra-abdominal infections;antimicrobial therapy;Asia;consensus | 公開日期: | 2007 | 卷: | v.30 | 期: | n.2 | 起(迄)頁: | 129-133 | 來源出版物: | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 摘要: | The selection of antimicrobial agents in the 2006 Guidelines (consensus statement) on Empiric Therapy for Complicated Intra-Abdominal Infections ( IAIs) in Asia was based on resistance and epidemiological data from the Asian region. In these 2006 guidelines, single agent therapy using the beta-lactam/beta-lactamase inhibitors ampicillin/sulbactam or cefoperazone -sulbactam is recommended for mild-to- moderate cases, while piperacillin- tazobactam is recommended for high-severity cases. When using carbapenems, ertapenem is recommended for mild-to-moderate cases, while imipenem and meropenem are recommended for high-severity cases. For combination regimes , two types of agents are recommended: cephalosporin-based and monobactam- based. For mild-to- moderate cases, a third generation cephalosporin plus metronidazole is recommended. For high-severity cases, a third or fourth generation cephalosporin plus metronidazole+ /- amikacin is recommended. For the monobactam-based regimen , aztreonam plus metronidazole is recommended for high- severity cases only. (c) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/89471 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。